Amiodarone Induced Epididymitis: A Case Report

dc.contributor.authorCicek, Tufan
dc.contributor.authorDemir, Canan Cicek
dc.contributor.authorCoban, Gokcen
dc.contributor.authorConer, Ali
dc.date.accessioned2019-12-25T13:10:13Z
dc.date.available2019-12-25T13:10:13Z
dc.date.issued2014
dc.description.abstractIntroduction: Amiodarone is an effective drug for life-threatening arrhythmias like recurrent ventricular fibrillation and atrial fibrillation. Amiodarone creates rarely genitourinary side effects are seen. These are epididymitis, testicular dysfunction and impotance. Amiodarone aggregates and triggers inflammation in the head of the epididym. Case report: We present the case of a patient who developed epididymitis after 17 months of amiodarone therapy, using a low dose (100 mg per day). Although cessation of medication or dose lowering was not performed, remission of the patient only by analgesics is a distinct case reported in urological literature. Conclusions: This case stresses the importance of considering an adverse effect of amiodarone treatment as a cause when making a differential diagnosis of epididymitis.en_US
dc.identifier.issn2074-1804
dc.identifier.issue1en_US
dc.identifier.urihttps://neoscriber.org/cdn/serve/313ea/597de0b1c1836f4840b74c4be59cfc191040fdf1/16117-pdf.pdf
dc.identifier.urihttp://hdl.handle.net/11727/4538
dc.identifier.volume16en_US
dc.identifier.wos000333960800005
dc.language.isoengen_US
dc.relation.isversionof10.5812/ircmj.13929en_US
dc.relation.journalIRANIAN RED CRESCENT MEDICAL JOURNALen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAmiodaroneen_US
dc.subjectEpididymitisen_US
dc.subjectSterileen_US
dc.titleAmiodarone Induced Epididymitis: A Case Reporten_US
dc.typearticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
16117-pdf.pdf
Size:
302.49 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: